ESC 365 - Effect of SGLT2i on myocardial remodeling due to cardiorenal syndrome in rat model of heart failure

Open Access

Effect of SGLT2i on myocardial remodeling due to cardiorenal syndrome in rat model of heart failure

Session: Pathophysiology and treatment

Topic: Heart Failure

Speaker: Doctor M. Sykora (Bratislava, SK)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Matus Sykora

Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava (Slovakia)

0 follower

6 more presentations in this session

Inflamed atrial tissues of patients with atrial fibrillation are characterized by pro-oxidant and pro-remodeling responses: synergistic inhibition by an SGLT2 inhibitor plus a GLP-1R activation

Speaker: Doctor W. Fakih (Strasbourg, FR)

Mural cell dysfunction contributes to diastolic heart failure by promoting endothelial dysfunction and vessel remodeling

Speaker: Professor E. Jones (Leuven, BE)

L-PGDS/ PGD2 is a regulator of cardiac metabolism during aging?

Speaker: Doctor L. Savchenko (Toulouse, FR)

Circulating low-grade inflammation in human pulmonary arterial hypertension promotes eNOS-NO/ROS imbalance: Involvement of the angiotensin and the endothelin pathways and prevention by EPA:DHA 6:1

Speaker: Ms H. MUZAMMEL (Strasbourg, FR)

Reversal of age-related diastolic dysfunction by micronized purified flavonoid fraction in rats with attenuation of low-grade inflammation, eNOS-NO/ROS imbalance, and left ventricular fibrosis

Speaker: Professor V. Schini-Kerth (Strasbourg, FR)

Access the full session

Pathophysiology and treatment

Speakers: Doctor M. Sykora, Doctor W. Fakih, Professor E. Jones, Doctor L. Savchenko, Ms H. MUZAMMEL...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources